• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从一个开处方的枢纽来看,远程医疗和丁丙诺啡获取的交织扩张。

The intertwined expansion of telehealth and buprenorphine access from a prescriber hub.

机构信息

VA Connecticut Healthcare System, West Haven, CT, USA; Yale University, School of Medicine, Department of Psychiatry, New Haven, CT, USA.

VA Connecticut Healthcare System, West Haven, CT, USA; Yale University, School of Nursing, Orange, CT, USA.

出版信息

Prev Med. 2021 Nov;152(Pt 2):106603. doi: 10.1016/j.ypmed.2021.106603. Epub 2021 May 8.

DOI:10.1016/j.ypmed.2021.106603
PMID:33974959
Abstract

In this manuscript, we describe how efforts to increase access to buprenorphine for Opioid Use Disorder (OUD) through a telemedicine hub before and since the COVID-19 pandemic have played out in the Veterans Healthcare Administration (VHA) in New England. We look at how the COVID-19 pandemic and subsequent spike in opioid overdoses tilted the risk: benefit calculation for tele-prescribing a controlled substance such as buprenorphine toward expanding access to tele-buprenorphine. We conclude that there is a need for tele-buprenorphine hubs that can fill gaps in geographically dispersed healthcare systems.

摘要

在本文中,我们描述了在 COVID-19 大流行之前和之后,通过远程医疗中心努力增加新英格兰退伍军人医疗保健管理局(VHA)阿片类药物使用障碍(OUD)患者获得丁丙诺啡的机会的情况。我们研究了 COVID-19 大流行和随后阿片类药物过量的激增如何改变了通过远程医疗开处像丁丙诺啡这样的受控物质的风险收益计算,从而有利于扩大远程丁丙诺啡的使用。我们的结论是,需要有远程丁丙诺啡中心来填补地理上分散的医疗系统中的空白。

相似文献

1
The intertwined expansion of telehealth and buprenorphine access from a prescriber hub.从一个开处方的枢纽来看,远程医疗和丁丙诺啡获取的交织扩张。
Prev Med. 2021 Nov;152(Pt 2):106603. doi: 10.1016/j.ypmed.2021.106603. Epub 2021 May 8.
2
Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder.比较美国患有阿片类药物使用障碍的退伍军人中远程医疗与面对面丁丙诺啡治疗的效果。
J Subst Abuse Treat. 2022 Feb;133:108492. doi: 10.1016/j.jsat.2021.108492. Epub 2021 May 28.
3
Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine.利用远程医疗增加农村诊所中患有阿片类药物使用障碍的退伍军人的丁丙诺啡获取途径。
Subst Abus. 2022;43(1):39-46. doi: 10.1080/08897077.2020.1728466. Epub 2020 Feb 20.
4
The COVID-19 pandemic and opioid use disorder: Expanding treatment with buprenorphine, and combining safety precautions with telehealth.新型冠状病毒肺炎疫情和阿片类药物使用障碍:扩大丁丙诺啡治疗,并将安全防范措施与远程医疗相结合。
J Subst Abuse Treat. 2022 Feb;133:108543. doi: 10.1016/j.jsat.2021.108543. Epub 2021 Jun 26.
5
The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review.COVID-19 对使用阿片类药物人群的医疗服务提供的影响:范围综述。
Subst Abuse Treat Prev Policy. 2021 Aug 9;16(1):60. doi: 10.1186/s13011-021-00395-6.
6
Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic.利用药剂师在 COVID-19 大流行期间维持和扩大阿片类药物使用障碍的丁丙诺啡供应。
Am J Health Syst Pharm. 2021 Mar 18;78(7):613-618. doi: 10.1093/ajhp/zxab003.
7
Low Threshold Telemedicine-based Opioid Treatment for Criminal Justice Involved Adults During the COVID-19 Pandemic: A Case Report.新冠疫情期间有犯罪记录的成年人基于低门槛远程医疗的阿片类药物治疗:病例报告。
J Addict Med. 2022;16(1):e59-e61. doi: 10.1097/ADM.0000000000000836.
8
Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island.利用远程医疗在 COVID-19 期间和之后改善丁丙诺啡的可及性:罗得岛的快速反应倡议。
J Subst Abuse Treat. 2021 May;124:108283. doi: 10.1016/j.jsat.2021.108283. Epub 2021 Jan 20.
9
COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management.COVID-19:改变阿片类药物使用障碍管理中远程医疗服务提供的催化剂。
Subst Abus. 2021;42(2):205-212. doi: 10.1080/08897077.2021.1890676. Epub 2021 Mar 8.
10
Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder.移动远程医疗在农村地区阿片类药物使用障碍患者丁丙诺啡治疗中的应用
JAMA Netw Open. 2021 Aug 2;4(8):e2118487. doi: 10.1001/jamanetworkopen.2021.18487.

引用本文的文献

1
Integrating Buprenorphine for Opioid Use Disorder into Rural, Primary Care Settings.将丁丙诺啡用于治疗阿片类药物使用障碍融入农村基层医疗环境。
J Gen Intern Med. 2024 Sep;39(12):2142-2149. doi: 10.1007/s11606-024-08898-1. Epub 2024 Jul 2.
2
Improving access to buprenorphine for rural veterans in a learning health care system.在学习型医疗保健系统中改善农村退伍军人获得丁丙诺啡的机会。
Health Serv Res. 2024 Dec;59 Suppl 2(Suppl 2):e14346. doi: 10.1111/1475-6773.14346. Epub 2024 Jul 2.
3
Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: A model-based analysis.
拟议的美国监管放宽政策下阿片类药物使用障碍治疗的估计效果和成本效益:基于模型的分析。
Drug Alcohol Depend. 2024 Mar 1;256:111112. doi: 10.1016/j.drugalcdep.2024.111112. Epub 2024 Feb 1.
4
Access to Medications for Opioid Use Disorder in Rural Versus Urban Veterans Health Administration Facilities.农村与城市退伍军人事务部医疗机构中阿片类药物使用障碍药物的可及性。
J Gen Intern Med. 2023 Jun;38(8):1871-1876. doi: 10.1007/s11606-023-08027-4. Epub 2023 Jan 23.
5
Behavior change, health, and health disparities 2021: Rural addiction and health.行为改变、健康和健康差距 2021:农村成瘾与健康。
Prev Med. 2021 Nov;152(Pt 2):106834. doi: 10.1016/j.ypmed.2021.106834. Epub 2021 Oct 7.